Market Newsdesk

NEW YORK
, Aug. 7, 2025 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of Biohaven Ltd. (NYSE: BHVN).

Shareholders who purchased shares of BHVN during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

CONTACT US HERE:

https://securitiesclasslaw.com/securities/biohaven-ltd-loss-submission-form/?id=159950&from=4

CLASS PERIOD:
March 24, 2023 to May 14, 2025

ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) The company’s product candidate, troriluzole’s regulatory prospects as a treatment for SCA, and/or the sufficiency of data that Biohaven submitted in support of troriluzole’s regulatory approval for this indication, were overstated; (ii) BHV-7000’s efficacy and clinical prospects as a treatment for bipolar disorder were likewise overstated; (iii) all the foregoing, once revealed, was likely to have a significant negative impact on Biohaven’s business and financial condition; and (iv) as a result, defendants’ public statements were materially false and misleading at all relevant times.

DEADLINE: September 12, 2025 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/biohaven-ltd-loss-submission-form/?id=159950&from=4

NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of BHVN during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is September 12, 2025. There is no cost or obligation to you to participate in this case.

WHY GROSS LAW FIRM? The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a company lead to artificial inflation of the company’s stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903

View original content to download multimedia:https://www.prnewswire.com/news-releases/biohaven-ltd-sued-for-securities-law-violations—contact-the-gross-law-firm-before-september-12-2025-to-discuss-your-rights–bhvn-302523867.html

SOURCE The Gross Law Firm

NEW YORK
, Aug. 7, 2025 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of iRobot Corporation (NASDAQ: IRBT).

Shareholders who purchased shares of IRBT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

CONTACT US HERE:
https://securitiesclasslaw.com/securities/irobot-corporation-loss-submission-form-2/?id=159947&from=4 

CLASS PERIOD:
January 29, 2024 to March 11, 2025

ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) iRobot overstated the extent to which the restructuring plan would help the Company maintain stability after the termination of the Amazon acquisition; (ii) as a result, it was unlikely that iRobot would be able to profitably operate as a standalone company; (iii) accordingly, there was substantial doubt about the Company’s ability to continue as a going concern; and (iv) as a result, defendants’ public statements were materially false and misleading at all relevant times.

DEADLINE: September 5, 2025 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/irobot-corporation-loss-submission-form-2/?id=159947&from=4

NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of IRBT during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is September 5, 2025. There is no cost or obligation to you to participate in this case.

WHY GROSS LAW FIRM? The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a company lead to artificial inflation of the company’s stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903

View original content to download multimedia:https://www.prnewswire.com/news-releases/investors-who-lost-money-on-irobot-corporationirbt-should-contact-the-gross-law-firm-about-pending-class-action—irbt-302523849.html

SOURCE The Gross Law Firm

NEW YORK
, Aug. 7, 2025 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of XPLR Infrastructure, LP f/k/a Nextera Energy Partners, LP (NYSE: XIFR).

Shareholders who purchased shares of XIFR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

CONTACT US HERE:

https://securitiesclasslaw.com/securities/xplr-infrastructure-lp-f-k-a-nextera-energy-partners-lp-loss-submission-form/?id=159948&from=4

CLASS PERIOD:
September 27, 2023 to January 27, 2025

ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) XPLR was struggling to maintain its operations as a yieldco; (ii) defendants temporarily relieved this issue by entering into certain financing arrangements, described herein, while downplaying the attendant risks; (iii) XPLR could not resolve those financings before their maturity date without risking significant unitholder dilution; (iv) as a result, defendants planned to halt cash distributions to investors and instead redirect those funds to, inter alia, resolve those financings; (v) as a result of all the foregoing, XPLR’s yieldco business model and distribution growth rate was unsustainable; and (vi) as a result, defendants’ public statements were materially false and misleading at all relevant times.

DEADLINE: September 8, 2025 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/xplr-infrastructure-lp-f-k-a-nextera-energy-partners-lp-loss-submission-form/?id=159948&from=4

NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of XIFR during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is September 8, 2025. There is no cost or obligation to you to participate in this case.

WHY GROSS LAW FIRM? The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a company lead to artificial inflation of the company’s stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903

View original content to download multimedia:https://www.prnewswire.com/news-releases/the-gross-law-firm-reminds-xplr-infrastructure-lp-fka-nextera-energy-partners-lp-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-september-8-2025–xifr-302523855.html

SOURCE The Gross Law Firm

NEW YORK
, Aug. 7, 2025 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT).

Shareholders who purchased shares of RCKT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

CONTACT US HERE:

https://securitiesclasslaw.com/securities/rocket-pharmaceuticals-inc-loss-submission-form/?id=159942&from=4

CLASS PERIOD:
September 17, 2024 to May 26, 2025

ALLEGATIONS: According to the complaint, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of RP-A501’s safety and clinical trial protocol; notably, that Rocket knew Serious Adverse Events (SAEs), including death of participants enrolled in the study, were a risk. In particular, Rocket amended the trial’s protocol to introduce a novel immunomodulatory agent to the pretreatment regimen without providing this critical update to shareholders. Such statements absent these material facts caused Plaintiff and other shareholders to purchase Rocket’s securities at artificially inflated prices. On May 27, 2025, Rocket announced that the FDA placed a clinical hold on the RP-A501 Phase 2 pivotal study after at least one patient suffered a Serious Adverse Event (SAE), ultimately, death, while enrolled in the study following a substantive amendment to the protocol that the Company failed to disclose to investors at the time management made the revision. In fact, Rocket stated that, while the patient was dosed in May, the decision to amend the protocol was made “several months” earlier. Despite this, Rocket made no attempt to alert investors or the public to the change until after the SAE occurred. Following this news, the price of Rocket’s common stock declined dramatically. From a closing market price of $6.27 per share on May 23, 2025, Rocket’s stock price fell to $2.33 per share on May 27, 2025, a decline of about 37% in the span of just a single trading day.

DEADLINE: August 11, 2025 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/rocket-pharmaceuticals-inc-loss-submission-form/?id=159942&from=4

NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of RCKT during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is August 11, 2025. There is no cost or obligation to you to participate in this case.

WHY GROSS LAW FIRM? The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a company lead to artificial inflation of the company’s stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903

View original content to download multimedia:https://www.prnewswire.com/news-releases/lost-money-on-rocket-pharmaceuticals-incrckt-join-class-action-suit-seeking-recovery–contact-the-gross-law-firm-302523846.html

SOURCE The Gross Law Firm

NEW YORK
, Aug. 7, 2025 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of Petco Health and Wellness Company, Inc. (NASDAQ: WOOF).

Shareholders who purchased shares of WOOF during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

CONTACT US HERE:
https://securitiesclasslaw.com/securities/petco-loss-submission-form/?id=159946&from=4 

CLASS PERIOD:
January 14, 2021 to June 5, 2025

ALLEGATIONS: (i) Petco’s pandemic-related tailwinds were unsustainable, as was its business model of selling primarily premium and/or high-grade pet food; (ii) accordingly, the strength of Petco’s differentiated product strategy was overstated; (iii) defendants downplayed the true scope and severity of the foregoing issues, the magnitude of changes needed to rectify those issues, and the likely negative impacts of their mitigation strategy on Petco’s comparable sales metric; (iv) accordingly, defendants overstated Petco’s ability to deliver sustainable, profitable growth; and (v) as a result, defendants’ public statements were materially false and misleading at all relevant times.

DEADLINE: August 29, 2025 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/petco-loss-submission-form/?id=159946&from=4

NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of WOOF during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is August 29, 2025. There is no cost or obligation to you to participate in this case.

WHY GROSS LAW FIRM? The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a company lead to artificial inflation of the company’s stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903

View original content to download multimedia:https://www.prnewswire.com/news-releases/the-gross-law-firm-notifies-petco-health-and-wellness-company-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline–woof-302523848.html

SOURCE The Gross Law Firm

NEW YORK
, Aug. 7, 2025 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of Hims & Hers Health, Inc. (NYSE: HIMS).

Shareholders who purchased shares of HIMS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

CONTACT US HERE:

https://securitiesclasslaw.com/securities/hims-hers-health-inc-loss-submission-form/?id=159944&from=4 

CLASS PERIOD:
April 29, 2025 to June 23, 2025

ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (1) Hims was engaged in the “deceptive promotion and selling of illegitimate, knockoff versions of Wegovy® that put patient safety at risk;” (2) as a result, there was a substantial risk that the Company’s collaboration with Novo Nordisk would be terminated; and (3) as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

DEADLINE: August 25, 2025 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/hims-hers-health-inc-loss-submission-form/?id=159944&from=4 

NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of HIMS during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is August 25, 2025. There is no cost or obligation to you to participate in this case.

WHY GROSS LAW FIRM? The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a company lead to artificial inflation of the company’s stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected] 
Phone: (646) 453-8903

View original content to download multimedia:https://www.prnewswire.com/news-releases/hims-lawsuit-alert-the-gross-law-firm-notifies-hims–hers-health-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-302523873.html

SOURCE The Gross Law Firm

NEW YORK
, Aug. 7, 2025 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of Replimune Group, Inc. (NASDAQ: REPL).

Shareholders who purchased shares of REPL during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

CONTACT US HERE:
https://securitiesclasslaw.com/securities/replimune-group-inc-loss-submission-form-3/?id=159956&from=4 

CLASS PERIOD:
November 22, 2024 to July 21, 2025

ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (1) defendants recklessly overstated the IGNYTE trial’s prospects, given material issues that defendants knew or should have known of, which resulted in the FDA deeming the IGNYTE trial inadequate and not well-controlled; and (2) as a result, defendants’ statements about Replimune’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

DEADLINE: September 22, 2025 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/replimune-group-inc-loss-submission-form-3/?id=159956&from=4 

NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of REPL during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is September 22, 2025. There is no cost or obligation to you to participate in this case.

WHY GROSS LAW FIRM? The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a company lead to artificial inflation of the company’s stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903

View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholders-that-lost-money-on-replimune-group-increpl-should-contact-the-gross-law-firm-about-pending-class-action—repl-302523845.html

SOURCE The Gross Law Firm

XIAMEN, China
, Aug. 7, 2025 /PRNewswire/ — Recently, POP Culture and Ciwen Media officially established a strategic cooperative relationship. This collaboration marks a significant step forward for POP Culture in deepening its layout within the Chinese Wave (Huáliú) culture and expanding channels for high-quality content distribution. The two parties will join forces, integrating their respective advantageous resources and core competencies, to jointly provide a robust support platform for outstanding singers, musicians, and their premium content within the domestic music and performance market.

After months of planning, refinement, and careful selection and evaluation of partners, POP Culture and Ciwen Media will collaborate in the second half of 2025 to launch exclusive tour projects for multiple artists, including Su Xingjie and Liu Dazhuang, in key cities across the country. The inaugural stop of these exclusive tours—the 2025 Su Xingjie “Do You Still Remember” Concert – Chengdu Stop—will grandly commence on August 30th at Hall No. 6 of the ZhengHuo Art Center in Chengdu.

As a pioneering enterprise deeply rooted in Chinese Wave culture and a trendsetter, POP Culture has consistently dedicated itself to exploring the music performance market and incubating and operating trendy IPs, accumulating profound industry resources and extensive operational experience. Ciwen Media, adhering to its dual-core driving model of “Endogenous Growth” + “Capital Platform Expansion of a Listed Company,” possesses a mature system in film and television production, artist management, and large-scale entertainment projects, boasting strong content production capabilities and significant industry influence. This cooperation represents not only a deep exploration of the commercial value of Chinese Wave music but also an active exploration into the industrialized operation of local cultural IPs.

Looking ahead, both parties will work together to continue leveraging their respective strengths and business potential. Through synergistic resource effects, they aim to facilitate the implementation of more high-quality performance projects, actively expand the innovative boundaries of the performance industry, and jointly contribute to the prosperous development of China’s music and entertainment industry. As strategic partners, both companies will grow together, actively promote industry progress, and bring a wider audience more “high-quality and diverse” cultural products.

About CPOP (Pop Culture Group Co., Ltd):

Pop Culture Group Co., Ltd is a cultural industry operation enterprise focused on the industrialization of Chinese Pop Culture, incorporated in the Cayman Islands with its main operations located in China. The company offers a range of services including live performances, artist management, intellectual property rights, film and television production, MCN (Multi-Channel Network), and entertainment marketing. Originally focused on hip-hop culture, Pop Culture Group Co., Ltd has evolved into a diversified group specializing in Chinese Pop Culture. Its comprehensive business ecosystem spans both online and offline platforms, including: (1) live entertainment events (such as concerts, music festivals, street dance competitions, and other performances); (2) digital entertainment services; (3) artist management and agency services; and (4) investment in and production of film and television content featuring elements of Chinese Pop Culture.

Forward-Looking Statements

This press release contains, “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. CPOP’s actual results may differ from their expectations, estimates and projections and consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “might” and “continues,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements include, but are not limited to, statements about: CPOP’s goals and strategies; CPOP’s future business development, financial condition and results of operations; expected changes in CPOP’s revenues, costs or expenditures; competition in the industry; relevant government policies and regulations relating to our industry; general economic and business conditions globally and in China; and assumptions underlying or related to any of the foregoing. CPOP cautions that the foregoing list of factors is not exclusive. CPOP cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. CPOP does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions or circumstances on which any such statement is based, subject to applicable law. Additional information concerning these and other factors that may impact our expectations and projections can be found in CPOP’s periodic filings with the SEC, including CPOP’s Annual Report on Form 20-F for the fiscal year ended June 30, 2024. CPOP’s SEC filings are available publicly on the SEC’s website at www.sec.gov. 

View original content:https://www.prnewswire.com/news-releases/pop-culture-and-ciwen-media-forge-strategic-partnership-to-jointly-create-a-new-chapter-for-chinese-wave-entertainment-302524325.html

SOURCE Pop Culture Group Co., Ltd

NEW YORK
, Aug. 7, 2025 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of Vestis Corporation (NYSE: VSTS).

Shareholders who purchased shares of VSTS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

CONTACT US HERE:
https://securitiesclasslaw.com/securities/vestis-corporation-loss-submission-form/?id=159941&from=4

CLASS PERIOD:
May 2, 2024 to May 6, 2025

ALLEGATIONS: According to the complaint, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of Vestis’ ability to grow its business; notably that Vestis would be unable to execute on planned strategic initiatives to drive purported improvements to the customer experience and its onboarding efforts in order to drive new customer growth, increased customer retention, and increased revenue from existing customers. On May 7, 2025, Vestis announced its financial results for the second quarter of fiscal 2025, withdrew its revenue and growth guidance for the full fiscal year 2025, and provided guidance for the third quarter of fiscal 2025 that fell significantly below market expectations. The Company attributed its poor results partially to “lost business in excess of new business,” but primarily on “lower adds over stops, which is how we describe volume changes with our existing customers.” The Company attributed its decision to pull full-year guidance and provide disappointing third quarter targets to the “increasingly uncertain macro environment.” Following this news, the price of Vestis’ common stock declined dramatically. From a closing market price of $8.71 per share on May 6, 2025, Vestis’ stock price fell to $5.44 per share on May 7, 2025, a decline of about 37.54% in the span of just a single day.

DEADLINE: August 8, 2025 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/vestis-corporation-loss-submission-form/?id=159941&from=4

NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of VSTS during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is August 8, 2025. There is no cost or obligation to you to participate in this case.

WHY GROSS LAW FIRM? The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a company lead to artificial inflation of the company’s stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903

View original content to download multimedia:https://www.prnewswire.com/news-releases/the-gross-law-firm-notifies-shareholders-of-vestis-corporation-vsts-of-a-class-action-lawsuit-and-an-upcoming-deadline-302523741.html

SOURCE The Gross Law Firm

NEW YORK
, Aug. 7, 2025 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of Alto Neuroscience, Inc. (NYSE: ANRO).

Shareholders who purchased shares of ANRO during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

CONTACT US HERE:

https://securitiesclasslaw.com/securities/alto-neuroscience-inc-loss-submission-form/?id=159953&from=4

CLASS PERIOD: This lawsuit is on behalf of a class consisting of all persons and entities that purchased or otherwise acquired: (a) Alto common stock pursuant and/or traceable to the Offering Documents issued in connection with the Company’s initial public offering conducted on or about February 2, 2024; and/or (b) Alto securities between February 2, 2024 and October 22, 2024, both dates inclusive.

ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) The Company’s product pipeline, ALTO-100, was less effective in treating major depressive disorder than defendants had led investors to believe; (ii) accordingly, ALTO-100’s clinical, regulatory, and commercial prospects were overstated; (iii) as a result, Alto’s business and/or financial prospects were overstated; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

DEADLINE: September 19, 2025 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/alto-neuroscience-inc-loss-submission-form/?id=159953&from=4

NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of ANRO during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is September 19, 2025. There is no cost or obligation to you to participate in this case.

WHY GROSS LAW FIRM? The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a company lead to artificial inflation of the company’s stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903

View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholders-that-lost-money-on-alto-neuroscience-incanro-should-contact-the-gross-law-firm-about-pending-class-action—anro-302523752.html

SOURCE The Gross Law Firm